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ABSTRACT
Introduction: To investigate safety of balloon catheter  for cervical ripening in women with term 
pre-labor rupture of membranes (PROM), and to compare the incidence of maternal and neonatal 
infections in women with PROM and women with intact membranes undergoing cervical ripening 
with a balloon catheter. Material and methods: This retrospective cohort study of 1923 women 
with term singleton pregnancy and an unfavorable cervix undergoing cervical ripening with a 
balloon catheter was conducted in Helsinki University Hospital between January 2014 and 
December 2018. For each case of PROM, two controls were assigned. The main outcome 
measures were the rates of maternal and neonatal infections. Statistical analyses were performed 
by SPSS. Results:  641 (33.3%) women underwent labor induction following PROM and 1282 
(66.6%) women with intact amniotic membranes. The rates of intrapartum infection (3.7% vs. 
7.7%; p=0.001) and neonatal infection (1.7% vs. 3.8%; p=0.01) were not increased in women 
induced by balloon catheter following PROM. Intrapartum infections were associated with 
nulliparity (OR 3.3, 95% CI 1.6–6.5), history of previous cesarean section (OR 2.8, 95% CI 1.2–
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interval of 48 h or more (OR 2.0, 95% CI 1.2–3.3). The risk of neonatal infection was associated 
with nulliparity (OR 3.3, 95% CI 1.4-8.0), gestational age ≥ 41 weeks (OR 1.9, 95% CI 1.09–3.36) 
and induction to delivery interval of 48 h or more (OR 3.4, 95% CI 1.9-6.0). Conclusions: Use of 
balloon catheter in women with term PROM appears safe and was not associated with increased 
maternal or neonatal infectious morbidity.
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INTRODUCTION
Pre-labor rupture of membranes (PROM), defined as rupture of membranes at least one hour prior 
to onset of regular contractions, occurs in approximately 8 % of term pregnancies.  Sixty percent 
of the women with PROM deliver spontaneously within 24 hours (1). Prolongation of onset of 
labor for more than 24 hours is associated with an increased incidence of chorioamnionitis and 
neonatal sepsis (1,2). There are multiple management guidelines for PROM, including expectant 
management and immediate induction of labor (IOL) with oxytocin or prostaglandins (1,3-5). The 
recent Cochrane review supports IOL within 24 hours from PROM for lower risk of maternal and 
neonatal infections without an increase in the rate of cesarean section (6).
An abundance of studies support the efficacy of balloon catheter (BC) for cervical ripening 
considering the low risk of uterine hyperstimulation, fetal heart rate abnormalities, and adverse 
maternal outcomes after previous cesarean section (7,8-10). However, most studies include only 
women with intact amniotic membranes, while the use of BC in women with ruptured amniotic 
membranes has raised concerns over infectious morbidity.  Only a few small studies with limited 
data exist on the safety of the use of BC in women with PROM. Reassuring results on the use of 
BC following term PROM have been reported by two relatively small retrospective cohort studies 
(11,12), a randomized controlled trial (RCT) of 188 women comparing BC and oral misoprostol 
for cervical ripening following term PROM (13) and a RCT comparing concurrent use of BC and 
oxytocin with oxytocin only in 128 women (14).  On the contrary, another RCT comparing 
concurrent BC and oxytocin use with oxytocin only in 201 preterm or term women reported 
increased rates of chorioamnionitis following the use of BC, although infections were associated 
with longer induction-to-delivery interval (15). 
The aim of this five-year cohort study was to assess the safety of use of BC for cervical ripening 
following PROM, and to compare the incidence of maternal and neonatal infections in women 
with PROM and women with intact amniotic membranes undergoing cervical ripening with BC. 
MATERIAL AND METHODS
This  cohort study of women ≥ 37 gestational weeks undergoing IOL and cervical ripening by BC 
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Gynecology in Helsinki University Hospital, with approximately 13 500 deliveries annually. All 
women with PROM, vital singleton pregnancy in cephalic presentation at ≥37 weeks of gestation, 
and an unfavorable cervix (Bishop score (16) <6) were included in the study. For each case of 
PROM, two controls of women undergoing cervical ripening by BC for any reason other than 
PROM were assigned. The controls were selected from the hospital database by including the one 
woman who had undergone cervical ripening by BC and given birth prior to the case, and the one 
who had undergone cervical ripening by BC and given birth following the case. 
PROM was diagnosed by clinical examination combined with a positive rapid vaginal insulin-like 
growth factor binding protein-1 dipstick test (ActimProm®, Medix Biochemica, Espoo, Finland). 
A single 40-80 ml BC (Rüsch 2 way Foley Couvelaire tip catheter size 22 Ch, Teleflex Medical, 
Athlone, Ireland) was used for cervical ripening in all women. According to the hospital 
management guidelines, the balloon was retained for a maximum of 8 hours in case of PROM, and 
24 hours in women with intact amniotic membranes. If the cervix remained unripe with Bishop 
score <6 after BC expulsion or removal, induction was continued at the discretion of the treating 
obstetrician. If Bishop score ≥6 was reached, IOL was continued by amniotomy in case of intact 
amniotic membranes, and oxytocin in the absence of spontaneous contractions. Oxytocin 
augmentation and continuous cardiotocography during labor were routinely used.
Group B Streptococcus (GBS) was tested in all women by a rapid qualitative in vitro GBS test 
(Xpert® GBS; Cepheid, Sunnyvale, CA, USA) at the time of admission. Administration of 
prophylactic antibiotics was started to all GBS-positive women at the time of rupture of 
membranes or at the time of diagnosing PROM. Benzylpenicillin was routinely used for antibiotic 
prophylaxis with the first dose of 2.4 g intravenously, followed by 1.5 g every 4 hours until 
delivery. In case of a penicillin allergy, clindamycin 900 mg or cefuroxime 1.5 g were 
administered every 8 hours intravenously. Additionally, according to the hospital policy, all 
women with ruptured membranes received one dose of prophylactic antibiotics during BC 
retention, regardless of the GBS-result. 
The primary outcomes were the rates of maternal and neonatal infections. Maternal infections 
were categorized as intrapartum (during labor) and postpartum (within one week from delivery). 
The criteria for intrapartum infection were maternal fever ≥ 38°C during labor and at least one of 
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discharge, total white cell count > 15E9/L. Postpartum infections included endometritis, cesarean 
or episiotomy wound infection, sepsis, and puerperal fever of unknown origin. Neonatal infections 
were categorized into blood culture positive sepsis, clinical sepsis, suspected sepsis, and other 
suspected infection by a neonatologist. Neonatal clinical sepsis was defined as blood culture 
negative infection with symptoms and signs consistent with sepsis (respiratory distress, apnea, 
tachycardia, poor perfusion, low blood pressure, fever, hypoglycemia or hyperglycemia, 
irritability, feeding problems, lethargy, convulsions) and abnormal blood values (C-reactive 
protein (>20 mg/l), leukocytosis or leucopenia, increased neutrophil precursors and 
thrombocytopenia). The cases of suspected sepsis had at least one symptom and at least one 
abnormal laboratory test value (as listed with clinical sepsis), and a positive response to antibiotic 
treatment.  
The secondary outcomes were the mode of delivery, postpartum hemorrhage, Apgar score, 
umbilical artery blood gas values, admission to neonatal care, and induction to delivery interval. 
The data on baseline characteristics and delivery outcomes were obtained from the hospital 
database. Late-term pregnancy was defined as gestational age 41+0-41+6 weeks and post-term 
pregnancy was defined as gestational age ≥42 weeks. Gestational diabetes was diagnosed by at 
least one pathological value in 2-hour oral glucose tolerance test. The BC retention time was 
defined as an interval from balloon insertion to spontaneous expulsion or removal. The induction 
to delivery interval was defined as the time from insertion of the BC to delivery. Failed induction 
was diagnosed after ruptured membranes and 12 hours of oxytocin administration without cervical 
change (17). Duration of labor was defined as the time from the start of regular contractions with 
cervical dilation of 6 cm to delivery.  
Statistical analyses were performed by using IBM SPSS Statistics for Windows, Version 26.0 
(IBM Corp., Armonk, NY, USA). Categorical variables were analyzed for odds ratios (OR) with 
95% confidence interval (CI). Categorical variables were compared by the chi-square test and 
Fisher’s exact test when appropriate. Data with continuous variables were performed by T-test 
when the data followed normal distribution and by a Mann-Whitney U test if the data did not 
follow normal distribution. Univariate and multivariate logistic regression analyses were 
performed to assess relative risk for intrapartum infection. Variables used in the multivariate 
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mass index, previous cesarean section, Bishop score, gestational age, gestational diabetes, need of 
oxytocin induction, epidural/spinal analgesia, and the induction to delivery interval ≥ 48 h. 
Adjusted OR with 95% CI were calculated by modelling the data to control for possible 
confounding factors. A p-value <0.05 was considered statistically significant.
Ethical approval
The study was approved by the Institutional Review Board of the hospital region (Helsinki and 
Uusimaa Hospital District Committee for Obstetrics and Gynecology), (nr. HUS/3172/2018, 
HUS/54/2019 and HUS/6/2015). Due to the retrospective nature of the study, written informed 
consent was waived by the Institutional Review Board according to national legislation (Medical 
Research Act 488/1999, chapter 2 a (23.4.2004/295), section 5 and 10a).
RESULTS  
A total of 1923 women were included in the study. Of these, 641 (33.3 %) underwent labor 
induction and cervical ripening by BC following PROM and 1282 (66.6 %) with intact amniotic 
membranes. The characteristics of the study population are presented in Table 1. The mean age of 
the women was 31.5 (5.3 SD) years, the mean body mass index 25.4 (5.4 SD) and the mean 
gestational age 40.4 (1.4 SD) weeks.  The women induced for reasons other than PROM were 
more obese, more often were smokers, and more often had gestational diabetes and late-term or 
post-term pregnancy (Table 1). The most common indications for labor induction in the non-
PROM group were post-date pregnancy (41 %), gestational diabetes (12.9 %), hypertensive 
disorders (11.0 %), maternal request for psychosocial reasons (8.0 %), intrahepatic cholestasis of 
pregnancy (7.2 %), oligohydramnios (5.1 %) and intrauterine growth restriction (4.7 %).
Table 2 presents the delivery outcomes. The median time from PROM to start of IOL was 27.3 h 
(range 1.7 – 328 h).  The median BC retention time was 4.0 (range 0.1 – 18.0) h in women with 
PROM and 6.4 (range 0.1 – 28.5) h in women with intact amniotic membranes (p<0.001). There 
were no significant difference in the rates of cesarean section between the groups (23.7 vs. 23.7 %; 
p=0.82) (Table 2). Induction to delivery interval was longer in women with intact amniotic 
membranes (26.2 [3.1-164] h vs. 17.4 [2.6 – 75.7] h; p< 0.001), but the duration of labor was 
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rates of low Apgar scores and low umbilical artery pH-values did not differ between the groups, 
but there were more admissions to NICU among the women with intact amniotic membranes 
(Table 2). 
The total rate of intrapartum infection was 6.4 % (n=123). The rate of intrapartum infection was 
lower in women induced for PROM compared to women induced with intact amniotic membranes 
(3.7 % vs. 7.7 %; p=0.001, OR 0.5, 95% CI 0.3-0.7) (Table 3). After adjustment with cofounding 
fa tors, intrapartum infections were associated with nulliparity (OR 3.3, 95% CI 1.6–6.5; p=001), 
history of previous cesarean section (OR 2.8, 95% CI 1.2–6.4; p=0.02), extended gestational age ≥ 
41 weeks (OR 1.9, 95% CI 1.2–3.0; p=0.003) and induction to delivery interval of 48 h or more 
(OR 2.0, 95% CI 1.2–3.3; p=0.005) (Table 4A). 
The total rate of postpartum infections was 2.5 % (n=49), and the rates of postpartum infections 
were similar between the women induced for PROM and the women induced for reasons other 
than PROM (2.0 % vs. 2.8 %; 0.31) (Table 3).  Eight cases (0.5 %) of blood culture positive 
septicemia occurred, two in the PROM group and six in the women with intact amniotic 
membranes (Table 3). Two of these occurred during labor and six occurred postpartum. 
The total rate of neonatal infections was 3.1 % (n=60), being 1.7 % among the women with 
PROM and 3.8 % among the women with intact membranes (p=0.01). One case of neonatal blood 
culture positive (Staphylococcus Aureus) sepsis occurred in the non-PROM group following 
vaginal delivery and no maternal infection. After adjustment, the risk factors for neonatal infection 
were nulliparity (OR 3.3, 95% CI 1.4-8.0; p=0.01), gestational age ≥ 41 weeks (OR 1.9, 95% CI 
1.09–3.36; p=0.03) and induction to delivery interval of 48 h or more (OR 3.4, 95% CI 1.9-6.0; 
p<0.001) (Table 4B).  When including only neonatal blood culture positive or clinical sepsis, the 
induction to delivery interval > 48 hours remained significant, OR 12.6 (95 % CI 3.5 – 45.2); 
p<0.001.
DISCUSSION
Our results suggest that use of BC for cervical ripening following PROM is safe and did not 
increase the incidence of maternal or neonatal infections compared to women undergoing IOL and 
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intrapartum and neonatal infections were higher in the women who underwent BC cervical 
ripening with intact amniotic membranes. However, this may be partly explained by the 
prophylactic antibiotic use during BC retention in the PROM group, and by the fact the women 
with intact membranes more often had risk factors such as obesity, smoking, gestational diabetics, 
and extended gestational age. The women without PROM also had longer induction to delivery 
intervals, which is known to be associated with increased rates of maternal and neonatal infection.  
PROM may represent early onset of labor, and therefore more appropriate comparison group may 
have been women with PROM who underwent cervical ripening by methods other than BC. We 
acknowledge another major limitation of the study being the prophylactic antibiotic use. In our 
study, prophylactic antibiotics were routinely administered during BC retention according to the 
hospital management policy. The authors are aware that the use of prophylactic antibiotics during 
BC retention in case of ruptured membranes is controversial and question this policy. On the 
contrary, the women who received antibiotic had significantly lower rates of infections. Following 
these encouraging results, we are currently reevaluating the antibiotic regimen policy in our 
hospital.  Another major weakness of the study is the lack of histopathological diagnosis of 
chorioamnionitis for all women with suspected chorioamnionitis. However, this is so far the 
largest cohort study on the safety of the use of BC in women with ruptured membranes, and adds 
to the limited data available. As large proportion of IOL is carried out due to PROM, and an 
increasing number of women have a history of previous caesarean section, it is important to assess 
the safety and feasibility on the use of BC in cases of ruptured membranes.
The duration of BC retention in both groups deviated from the hospital guidelines of eight hours in 
case of ruptured membranes and 24 hours in case of intact membranes. However, the duration of 
BC retention was not associated with the maternal or neonatal infections. Our results suggest that 
the BC can safely remain in the cervical canal for at least 8 hours following PROM, when 
prophylactic antibiotics are used during BC retention. In contrast, a previous study reported an 
increase in cervical pathogenic microbes, such as GBS, Candida albicans and Candida glabrata, 
and Gardnerella vaginalis during BC retention (18). In previous studies, BC retention time of 12–
24 hours is frequently described (19,20), although a Dutch study used a maximum of 96 hours 
with BC replacement every 24–48 hours, with no increase in the rates of maternal and neonatal 
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were included in the management protocol. Furthermore, only few trials were explicit about the 
inclusion and management GBS-colonized women.
The rates of maternal intrapartum infections and postpartum infections in our study are consistent 
with the previously shown 7% rate of chorioamnionitis, and the 3.5% rate of postpartum 
endometritis following labor induction (22,23). Similar reassuring results on the use of BC 
following PROM at term have previously been reported by a small Swedish pilot study (n=18) 
(24), an American retrospective cohort study (n=122) (11) and by a Finnish randomized 
multicenter trial (n=188) (13) that recorded no increase in infections following BC use compared 
to oral misoprostol. Another retrospective study showed a trend towards a higher rate of 
chorioamnionitis in 43 women undergoing IOL by BC following PROM, compared with 
intravaginal misoprostol or intravenous oxytocin use (12). However, after adjustment, the increase 
was due to nulliparity and intrauterine pressure catheter use (12). Also in our study, nulliparity 
was associated with an increased risk for intrapartum infections. Increased risk of 
chorioamnionitis has been demonstrated in nulliparous women remaining in the latent phase for 
more than 12-15 hours (25,26,), as also seen in our study, in which maternal and neonatal 
infections were associated with prolonged induction to delivery interval of ≥48 hours. 
Interestingly, duration of PROM or GBS colonization were not associated with an increased risk 
for maternal or neonatal infections. In our clinic, GBS colonized women are induced the latest in 
12 h following PROM, while the GBS-negative women are managed expectantly for 24 h.
The 1.7 % rate of neonatal infections following IOL in women with PROM was in line with the 
results of previous studies (22, 27). However, among the women induced for reasons other than 
PROM, the rate of neonatal infections was more than doubled. This may be partially explained by 
the longer induction to delivery interval and the higher rate of maternal intrapartum infections in 
the non-PROM group, as well as the antibiotic prophylaxis protocol which may have led to a 
reduced rate of infections in the PROM group. One case of blood culture positive neonatal sepsis 
occurred, which parallels the previously reported global sepsis incidence of approximately 1 per 
1000 live births (28, 29). There were more NICU admissions in the women induced for reasons 
other than PROM, which may  have resulted from the higher neonatal infections rate as well as the 
pregnancy complications that led to labor induction, such as post-term pregnancy, gestational 
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A randomized trial comparing 62 women with concurrent use of BC and oxytocin infusion to 66 
women with oxytocin infusion alone reported a 10 % rate of chorioamnionitis following the use of 
BC, although this was not statistically significantly higher compared to the 5 % rate of 
chorioamnionitis ion the oxytocin only group (15).  Another RCT compared 93 women with 
concurrent use of BC and oxytocin to 108 women with oxytocin induction alone. They recorded 7 
% chorionamnionitis rate on the BS group compared to 0 % in the oxytocin group (p<0.01) (14). 
Those with suspected intra-amniotic infection had a 9-hour longer induction to delivery interval 
than those without suspected infection (14). In this study BC was retained for 12 hours and the use 
of fetal scalp electrode was significantly more frequent in the BC group, although in their 
regression model it was not considered significant (14). However, these studies included also 
cases of preterm premature rupture of membranes, while the current study focused on women with 
term PROM. Additionally, the two previous studies included oxytocin use in women with unripe 
cervices, while our study concentrated on cervical ripening with BC and oxytocin was only started 
when Bishop score of six or more was reached. Contrarily, the Cochrane review suggests similar 
labor outcomes in women with PROM and an unfavourable cervices when comparing use of 
oxytocin and prior cervical ripening by prostaglandins (6). In our previous study, BC and 
misoprostol were as effective in labor induction following prolonged PROM (13). Thus, one may 
speculate is the use of BC an unnecessary intervention following PROM, and would oxytocin 
induction without prior cervical ripening be as effectively. Further studies are needed to 
substantiate the benefits of use of BC in women with prolonged PROM.  
CONCLUSION
Our results suggest that with regards to maternal and neonatal infectious morbidity, BC appears a 
safe method for cervical ripening in women with ruptured membranes when prophylactic 
antibiotics are used. Intrapartum and neonatal infections in our study were associated with 
nulliparity, history of previous cesarean section, gestational age of ≥41 weeks, and prolonged 
induction to delivery interval of 48 hours or more. Further investigations, ideally a randomized 
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TABLES
Table 1. The characteristics of the study population (n=1923)
PROM non-PROM
 n % n %
p-value
N 641 33.3 1282 66.7
Maternal age ≥ 37 years 111 17.3 218 17.0 0.86
Nulliparous 429 66.9 663 51.7 <0.001
Maternal height <164cm¹ 257 40.2 466 36.3 0.10
Late-term 129 20.1 628 49.0 < 0.001
Post-term 136 21.2 856 66.8 < 0.001
IVF 28 4.4 69 5.4 0.34
Smoking 49 7.6 139 10.8 0.03
BMI ≥30 kg/m² 81 12.7 264 20.6 < 0.001
Gestational diabetes³ 126 20.1 419 32.7 < 0.001
Previous cesarean section 110 17.2 166 12.9 0.01
GBS colonization⁴ 131 21.3 310 24.3 0.15
¹Missing values n= 2 (case).
²missing values n=1 (case) and n=1 (control).
³missing values n=15 (case).
⁴missing values n= 26 (case) and n=4 (controls).
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n % n %
Epidural/spinal analgesia 520 81.1 1028 80.2 0.63
Oxytocin for labor induction 311 57.2 494 50.9 0.02
Oxytocin augmentation 544 84.9 970 75.7 < 0.001
Operative vaginal delivery 77 12.0 151 11.8 0.88
Cesarean section 152 23.7 298 23.7 0.82
Failure to progress1 100 15.6 137 10.7 0.002
Fetal distress 38 5.9 120 9.4 0.010
Intrapartum infection 4 0.6 26 2.0 0.02
Other indication2 10 1.6 15 1.2 0.48
Post-partum hemorrhage ≥ 1000 ml 99 15.4 190 14.8 0.72
Rupture of membranes to delivery interval ≥ 
24 h
584 91,1 162 12,6 <0.001
Duration of labor (h; median [range]) 7.7 0.9-36.5 6.7 0.4-31.3 < 0.001
Induction to delivery interval (median; range) 17.4 2.6-75.7 26.2 3.2-163.7 <0.001
Induction to delivery interval ≥ 24 h 184 28.7 691 53.1 < 0.001
Induction to delivery interval ≥ 48 h 17 2.7 192 15.0 < 0.001
Birthweight (g; mean [SD]) 3430 440 3560 500 <0.001
5 min Apgar score <7 22 3.4 43 3.4 0.97
Umbilical artery pH ≤ 7.05 12 1.9 20 1.6 0.66
Umbilical artery BE ≤ 12 9 1.4 22 1.8 0.57
NICU 15 2.3 93 7.3 <0.001
1Failed vacuum delivery: PROM group n=3; non-PROM group n=9.  
2PROM group: fetal malpresentation (n=2), maternal request (n=1), placental abruption (n=3), umbilical cord prolapse 
(n=4); Non-PROM: fetal malpresentation (n=2), maternal request (n=3), placental abruption (n=2), umbilical cord 
prolapse (n=1), preeclampsia (n=7).
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Table 3. Infectious morbidity
PROM (n=641) Non-PROM (n=1282) p-value
 n % n %
Maternal intrapartum infection 24 3.7 99 7.7 0.001
Blood culture positive sepsis1 6 0.5
Maternal post-partum infection 13 2.0 36 2.8 0.31
Endometritis 5 0.8 20 1.6 0.16
Cesarean section wound infection 2 0.3 9 0.7 0.36
Abdominal/pelvic infection 1 0.2 4 0.3 0.67
Other2 3 0.5 3 0.2 0.41
Blood culture positive sepsis3 2 0.3
Neonatal infection 11 1.7 49 3.8 0.01
Blood culture positive sepsis 0 1 0.001
Clinical sepsis 1 0.2 8 0.6 0.51
Suspected sepsis 9 1.4 35 2.7 0.07
Other suspected infection 1 0.2 5 0.4
1Stafylococcus epidermoides n=1, Stafylococcus anginosus n=1, Group B Streptococcus (GBS) n=1, Stafylococcus 
aureus n=1, Grannulicatella elegans n=1, Enterococcus fecalis n=1
2PROM group: episiotomy wound infection (n=1), urinary tract infection (n=2); Controls: episiotomy wound infection 
(n=1), urinary tract infection (n=1), pneumonia (n=1)
3Entorococcus faecalis n=1, Escherichia coli with Siprolla n=1










This article is protected by copyright. All rights reserved
Table 4A. Unadjusted and adjusted risk factors for maternal intrapartum infection
Unadjusted intrapartum infection Adjusted intrapartum infection
OR CI (95 %) p-value OR CI (95 %) p-value
Nulliparity 2.4 1.6-3.6 <0.001 3.3 1.6–6.5 0.001
Maternal age ≥37 0.6 0.3-1.0 0.047 0.7 0.4–1.3 0.28
Height <160cm 1.1 0.7-1.5 0.743 1.1 0.7–1.6 0.70
PROM 0.5 0.3-0.7 0.001 0.6 0.3–1.1 0.08
IVF 1.1 0.5-2.5 0.735 1.3 0.6–3.0 0.54
Smoking 0.9 0.5-1.7 0.748 0.8 0.4–1.5 0.44
BMI ≥ 30 1.5 1.0–2.4 0.049 1.6 1.0–2.6 0.06
Previous CS 1.1 0.6-1.8 0.722 2.8 1.2–6.4 0.02
Bishop ≤ 3 2.0 1.2–3.1 0.004 1.3. 0.7–2.4 0.40
Gestational age ≥41 weeks 2.1 1.5–3.1 < 0.001 1.9 1.2–3.0 0.003
Need of oxytocin for IOL 1.1 0.7-1.5 0.787 1.0 0.6–1.5 0.91
Epidural/spinal analgesia 2.1 1.2-3.8 0.010 1.3 0.7–2.7 0.42
Gestational diabetes 1.2 0.8-1.7 0.425 1.3 0.8–2.0 0.30
GBS colonization 0.5 0.3-0.9 0.013 0.5 0.3–0.8 0.008
Induction to delivery interval ≥48 h 3.2 2.1-5.0 < 0.001 2.0 1.2–3.3 0.005
PROM, pre-labor rupture of membranes; IVF, in-vitro fertilization; BMI, body mass index; IOL, induction of labor; 
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Table 4B. Unadjusted and adjusted risk factors for neonatal infection
 Unadjusted neonatal infection Adjusted neonatal infection
OR CI (95 %) p-value OR CI (95 %) p-value
Nulliparity 3.9 2.2-6.9 <0.001 3.3 1.4–8.0 0.01
Maternal age ≥37 0.8 0.4-1.5 0.543 1.1 0.5-2.3 0.38
Height <160cm 0.7 0.4-1.2 0.172 0.8 0.4-1.3 0.15
PROM 0.5 0.3-0.8 0.007 0.7 0.3-1.7 0.46
IVF 1.8 0.8-4.1 0.140 1.6 0.6-4.2 0.31
Smoking 1.8 1.0–3.3 0.058 1.6 0.7-3.2 0.25
BMI ≥ 30 1.0 0.6-1.8 0.936 0.9 0.4-1.0 0.73
Previous CS 0.5 0.2-1.2 0.124 0.5 0.1-2.6 0.40
Bishop ≤ 3 1.7 1.0–2.9 0.055 1.2 0.6-2.7 0.61
Gestational age ≥41 weeks 2.5 1.6–3.9 < 0.001 1.9 1.1–-3.4 0.03
Need of oxytocin for IOL 1.2 0.7-2.0 0.479 1.1 0.7–1.9 0.69
Epidural/spinal analgesia 1.4 0.8-2.7 0.256 1.1 0.5-2.6 0.77
Gestational diabetes 1.1 0.7-1.9 0.587 1.2 0.7-2.2 0.52
Maternal GBS colonization 0.5 0.3-1.0 0.039 0.4 0.2–0.9 0.03
Induction to delivery interval ≥ 48 h 4.5 2.8-7.3 < 0.001 3.4 1.9–6.0 < 0.001
PROM, pre-labor rupture of membranes; IVF, in-vitro fertilization; BMI, body mass index; IOL, induction of labor; 
GBS, Group B Streptococcus. 
